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NZB mice develop an autoimmune syndrome that has been under study for many 
years  (1-4).  Both  B  cell  hyperactivity  and  abnormal  T  cell  function  have  been 
described  in  these  mice  (2-9).  In  addition,  NZB  mice  have  been  found  to  have 
subnormal  function  of the  thymic  epithelium  and  histologic  abnormalities  of the 
thymus  (10,  11).  Despite  the  thymic  defect,  NZB  disease  has  been  transferred  to 
histocompatible (H-2  a) recipients with marrow cells (12-16), and, moreover, athymic 
NZB mice rapidly develop autoimmunity (I 7). Superficially, such studies suggest that 
the NZB B cell is entirely responsible for disease. However, both genetic studies  (18- 
22)  and reconstitution  studies  (23,  24)  suggest that excessive B cell activity may be 
dissociated  from other aspects of NZB  disease  and  that  NZB T  cells contribute  to 
maximum  disease  expression.  Despite  >20  yr of study  of NZB  mice,  the  relative 
contributions of NZB thymic epithelium and marrow pre-T cell programming to the 
production of abnormal NZB thymocytes or NZB T  cells has never been elucidated. 
Mouse models of human systemic lupus share certain common features:  autoanti- 
body  production,  immune  complex  disease,  B  cell  hyperactivity,  and  a  defect  in 
experimental tolerance (3-7, 24,  25). The defect in experimental tolerance has served 
as a marker for, and correlate of, the potential for the development of the autoimmune 
syndrome (4,  23,  26-29).  Tolerance to bovine gamma globulin  (BGG) 1 and human 
gamma globulin (HGG) has been studied most extensively. 
In recent years we have been dissecting the tolerance defect in NZB mice by using 
a  reconsitution  system  in  which  (NZB  ×  DBA/2)F1  mice  (H-2 am)  are  neonatally 
thymectomized, lethally irradiated as adults, and repopulated with thymocytes or T 
cell-depleted  bone marrow cells from one or both parents.  We first  found  that  the 
major defect  in  BGG tolerance  induction  was associated with  the  NZB  thymocyte 
(23).  Subsequently, we found that androgens could suppress this defect (24). 
In the above studies, all of the recipients had been neonatally thymectomized. As 
a result, there was no possibility for donor NZB stem cells to differentiate into T  cells 
in the normal, nonautoimmune,  intrathymic environment. The donor NZB thymo- 
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phosphate-buffered saline; BSS, Hanks' balanced salt solution; C, complement; CFA, complete Freund's 
adjuvant. 
Journal of Experimental Medicine • Volume 155, April 1982  1025-1036  1025 1026  PRE-T  CELL DEFECT  IN NZB  MICE 
cyte, before transfer, had been derived from NZB marrow pre-T cells and then had 
been  exposed  to  the  NZB  thymic  microenvironment. Thus,  the  NZB  thymocyte 
defect, which ted to an abrogation of tolerance, could have resulted from an abnor- 
mality of a  marrow  pre-T stem  cell or  from  an abnormality imposed by the  NZB 
thymic microenvironment,  especially the NZB thymic epithelium. Moreover, because 
the  NZB  tbymocyte contributes to maximum autoimmunity in the recipients (23), 
the  uncertainty regarding the  basis for  the  NZB  thymocyte defect  takes  on added 
importance. We therefore set out to determine whether or not the NZB marrow pre- 
T  cell,  in the  absence of abnormal NZB  thymic epithelium, contains information 
necessary and sufficient to result in the development of an abnormal thymocyte that 
would prevent tolerance induction. In the experiments reported  herein, we demon- 
strate that the NZB marrow pre-T cell does, in fact, develop into a  fully abnormal T 
cell, even in a  nonautoimmune thymus. 
Materials and Methods 
Mice.  NZB/N  female mice were  obtained from  the  Small Animal Section, Division of 
Research  Services,  National Institutes of Health, Bethesda, MD.  DBA/2J female and male 
mice were obtained from The Jackson Laboratory, Bar Harbor, ME. (NZB × DBA/2)F1 female 
and  male mice were  derived  by mating female NZB/N with  male DBA/2  mice.  In each 
experiment, approximately eight mice were included in each treatment group. 
Thymectomies.  Neonatal thymectomy in (NZB X DBA/2)F1 mice was accomplished through 
a parasternal incision, as previously described (23). Briefly,  1-d-old mice were anesthetized by 
chilling in ice. While viewing through a dissecting microscope,  a parasternal incision was made, 
and the thymic lobes were removed by suction. The incision was closed with 6-0 silk and flexible 
collodion. The mice were  returned to their mothers after the procedure. Survival was >95%. 
Completeness of thymectomy was confirmed at autopsy. 
Castration.  Male  (NZB  X  DBA/2)F1 mice were  castrated  at  2-3 wk of age through two 
vertical intraperitoneal incisions or a single scrotal incision, as previously described (24). 
Thymic Epithelial Grafting.  Thymus glands were harvested from  1-d-old NZB, DBA/2, and 
(NZB X DBA/2)F1 female mice. The thymus was placed in phosphate-buffered saline, pH 7.2 
(PBS), and then exposed  to 650 rad gamma radiation from a 13VCs source to eliminate thymic 
lymphocytes. The remaining thymic epithelial tissue was  implanted into neonatally thymec- 
tomized female and neonatally thymectomized castrated male (NZB ×  DBA/2)F1 mice. Graft 
recipients were 2-3 wk of age at the time of implantation. The procedure was performed under 
ether anesthesia. A left flank incision was made through the skin and subcutaneous tissues to 
expose the left kidney. With the aid of a dissecting microscope, the renal capsule was incised, 
and  one  lobe  of an  irradiated  donor  thymus was  implanted. The  deep  fascia,  overlying 
subcutaneous tissues, and skin were closed using 6-0 silk. The recipients tolerated the procedure 
well, as indicated by a >95% survival. Recipients were returned to their mothers until weaning. 
Graft survival and repopulation with lymphocytes was  determined at  the conclusion of the 
experiment by direct visualization at autopsy and histological examination. 
Cell Harvest.  3- to 4-wk-old  NZB and DBA/2 female mice were  used as donors for bone 
marrow and thymocytes. All mice were sacrificed by cervical dislocation. The cell medium used 
in all experiments was Hanks' balanced salt solution (BSS), pH 7.2, containing 15 mM N-2- 
hydroxyethylpiperazine-N'-2-ethanesulfonic  acid (Hepes),  100 U/ml penicillin, and 100 ~g/ml 
streptomycin. 
Preparation of Cells for  Transfer.  T  cell  depletion of bone marrow  cells  was  carried  out 
according to a  modified protocol taken from Longo and Schwartz  (30). All marrow donors 
were  injected intraperitoneally 3 d  and  1 d  before killing with 0.1  ml of rabbit anti-mouse 
thymocyte serum (Microbiological Associates, Walkersville, MD). In addition, 2 d before killing, 
the donor mice were injected intraperitoneally  with 5 mg of hydrocortisone sodium succinate 
(Upjohn Company, Kalamazoo, MI). The bone marrow was flushed from the humeri, tibiae, 
and femora of the donor, using a 25-gauge needle and cold BSS. The harvested marrow was LASKIN ET AL.  1027 
then treated with anti-thy-1.2 plus complement, as described previously (23, 24). Briefly, to ~5 
×  l0  s nucleated bone marrow cells in 14.5 ml of medium was added 0.5 ml ofAKR anti-C3H 
thymocyte serum previously prepared (31). The cells were then incubated at room temperature 
for 30 min with gentle rotation. After one wash, the cells were resuspended in 25 ml of medium 
containing  10%  rabbit  complement  (Low-Tox  M  complement,  Cedarlane  Laboratories, 
Hornsby, Ontario, Canada) and incubated for 30 min at 37°C. Cellular viability was deter- 
mined by trypan blue exclusion. 
Reconstitution of  Irradiated Mice.  Recipient mice at 12-16 wk of age were irradiated with 850- 
950 rad from either a Phillips RT 250 double tube 250 kVp x-ray machine or a  137Cs gamma 
irradiator (Gammacell 40, Atomic Energy of Canada Ltd.)  at  126 rad/min. NZB mice were 
given the higher dose of irradiation in accordance with the findings of Morton and Seigel (32). 
Approximately 4 h  later, the recipients were given a single intravenous injection containing 
107 bone marrow cells from the appropriate strain with or without 5 ×  10  7 thymocytes from the 
appropriate donor. Mice were then placed in a laminar flow hood and given pH 2.5 drinking 
water plus standard mouse chow ad lib. Mice irradiated but not reconstituted all died within 10 
d.  In experiments in which  marrow  alone was  given,  the  mice were  tolerized  8  wk  after 
reconstitution; mice given marrow plus thymocytes were tolerized 2 wk after transfer. 
Tolerization and Immunization with BGG.  BGG (Cohn Fraction II, Mann Research Laborato- 
ries,  New  York)  dissolved  in  PBS,  pH  7.2, at  40  mg/ml  was  spun  in a  Beckman  L2-65 
ultracentrifuge (Beckman Instruments, Inc., Fullerton, CA) using a fixed angle rotor (type 65) 
at  105,000 g  for 2 h.  As outlined previously (24),  the  top one-third of the ultracentrifuged 
preparation was removed, and 10 mg of deaggregated BGG was  immediately injected intra- 
peritoneally into each animal, These mice and untreated controls were challenged intraperito- 
neally 10 d later with 0.5 mg BGG emulsified with complete Freund's adjuvant (CFA).  Mice 
were bled  10 and 30 d after challenge by retro-orbital puncture under light ether anesthesia. 
After clotting at  room temperature, the sera were removed, clarified by centrifugation, and 
stored at -20°C until assayed. 
Assay of Antibodies to BGG.  The solid-phase immunoradiometric assay was used as outlined 
previously (24). Briefly, a flexible round-bottomed micotiter plate (Cook Co., Alexandria, VA) 
was coated with a  10/~g/ml solution of chromotographically pure bovine IgG (N. L. Cappel 
Laboratories, Cochranville, PA). After blocking the plate with a 0.1% solution of rabbit serum 
albumin, the plates were used for  the assay.  50/tl of a  1:50 dilution of serum samples and 
standards in 0.05% Tween  20-PBS  were  added  in triplicate to  the  wells.  The plates  were 
incubated for 75 min at room temperature. After washing with distilled water, 50 p.1 of 0.05% 
3  Tween 20-PBS containing 20 ng of  H-labeled, affinity-purified rabbit anti-mouse Ig (anti-Ig) 
(23) were added to each well for  75 min at room temperature. After extensive washing with 
distilled water, the wells were individually  cut out, and the amount of bound 3H was determined 
in a liquid scintillation counter. The amount of labeled anti-mouse Ig bound per ml of sample 
was calculated as: 
(cpm -  background) ×  dilution factor 
#g 3H-labeled anti-Ig bound/ml serum = 
specific activity of3H-labled anti-Ig 
Statistical Analyses.  Groups of mice were compared using Student's t test. 
Results 
Effect  of NZB  Bone  Marrow  Stem  Cells  on  BGG  Tolerance  Induction.  NZB  mice are 
resistant to induction of tolerance to ultracentrifuged BGG, a defect that maps to the 
NZB  thymocyte (23).  To determine whether this defect  resides only in the mature 
NZB thymocyte or is also present  in a  prethymocyte stem cell, a  series of adoptive 
transfer experiments was designed. Neonatally thymectomized, adult irradiated, (NZB 
×  DBA/2)F1  mice were  reconstituted with  107  T  cell-depleted NZB  marrow  cells. 
One group had been given, at 2 wk of age, a DBA/2 thymic epithelial graft implanted 
under the renal capsule. The other two  thymectomized groups were given 5  ×  10  v 
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The  neonatally  thymectomized  mice  reconstituted  with  NZB  marrow  and  NZB 
thymocytes failed to become tolerant, whereas those thymectomized mice given NZB 
marrow  and  DBA/2  thymocytes were  found  to  be  tolerant  to  BGG  (Fig.  1).  Mice 
with  an  intact  thymus  reconstituted  with  NZB  marrow  failed  to  become  tolerant 
(Fig.  1),  despite the absence of administered NZB thymocytes. Similarly, mice with 
DBA/2  thymic epithelial grafts reconstituted with  NZB  marrow  cells also failed to 
become tolerant. These experiments suggested that a thymus must be present to allow 
NZB  marrow  thymocyte  precursors  to  develop  into  cells  that  prevent  tolerance 
induction. Moreover, the NZB marrow thymocyte precursors were able to differentiate 
into abnormal thymocytes in the thymus of an animal normally tolerant to BGG. 
The Effect of the Bone Marrow Stem Cell Donor on  Tolerance Induction.  Based upon the 
results shown  in Fig.  1, the administration of NZB bone marrow to a  nonthymecto- 
mized histocompatible recipient  should  create  a  nontolerant  state  in  the  recipient. 
This  hypothesis  was  tested  using  lethally  irradiated,  nonthymectomized  (NZB  × 
DBA/2)F:  female  recipients  of T  cell-depleted bone  marrow  from  either  NZB  or 
DBA/2 female donors. 
As  predicted,  the  recipients  of  NZB  marrow  were  not  tolerant  to  BGG;  this 
contrasted with normal tolerance induction in the recipients of DBA/2 marrow  (Fig. 
2). Because both marrow grafts were exposed to the same (NZB X  DBA/2)F: thymic 
microenvironment,  it  would  seem  that  the  marrow  pre-T  stem  cells  are  prepro- 
grammed to differentiate into thymocytes that allow or prevent tolerance. A  thymus 
appears to be necessary for stem cell maturation;  however, the source of the thymus 
might not be critical for the expression of susceptibility or resistance to tolerance. 
The Role of the Host Environment in Promoting Tolerance Induction to BGG.  The previous 
experiments  indicated  that  the  failure  of NZB  mice  to  become  tolerant  to  BGG 
depends  upon  the  NZB  marrow  prethymocyte  stem  cell.  Additional  studies  were 
performed to examine this conclusion. Nonthymectomized NZB, DBA/2, and  (NZB 
X  DBA/2)F: female mice were lethally irradiated and reconstituted with  10 7 T  cell- 
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Fro.  1.  Lethally irradiated (NZB X DBA/2)F1 mice were reconstituted  with NZB marrow pre- 
treated with anti-Thy-1.2 + C. Neonatally thymectomized recipients given NZB thymocytes failed 
to become tolerant, whereas those given DBA/2 thymocytes became tolerant (compare the first two 
lines). NZB marrow plus a DBA/2 thymic epithelial  graft failed to lead to tolerance.  Similarly, 
NZB marrow given to a nonthymectomized recipient also gave an NZB-like nontolerant  response. 
Thus, NZB marrow allowed to mature in association with thymic epithelium  led to a nontolerant 
result. The results shown were from sera obtained 30 d after challenge. Similar results were found 
10 d after challenge (data not shown). BONE MARROW 
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Fio.  2.  Lethally irradiated  (NZB X DBA/2)F1 mice, not thymectomized, were reconstituted with 
T cell-depleted marrow from NZB or DBA/2 donors. Recipients of DBA/2 marrow became tolerant, 
whereas recipients of NZB marrow produced substantial amounts of antibody after challenge. This 
was more apparent 30 d  after challenge than 10 d  after challenge. 
depleted NZB or DBA/2 bone marrow cells. All recipients of NZB marrow, regardless 
of the strain, failed to become tolerant to BGG.  The antibody responses of the three 
groups receiving NZB marrow were all quite substantial  and equivalent  (Fig.  3).  In 
contrast,  the DBA/2  and  (NZB  X  DBA/2)Fa  recipients  of DBA/2  marrow demon- 
strated  equally  tolerant  responses  to  challenge  (Fig.  3).  The  NZB  recipients  of 
DBA/2  bone marrow had a significantly greater response than did the other DBA/2 
bone marrow recipient groups. However, the response in this group of NZB recipients 
of DBA/2  marrow was less than  the nontolerant responses seen  in  the  DBA/2  and 
(NZB  x  DBA/2)F1  recipients  of NZB  marrow.  These  results  support  the  previous 
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FIC.  3.  Nonthymectomized NZB,  DBA/2, or  (NZB  X  DBA/2)F1  mice were  lethally irradiated 
and  reconstituted with either NZB or  DBA/2  marrow  that  had been T  cell  depleted.  For each 
recipient strain, NZB marrow led to significantly more anti-BGG than did DBA/2 marrow. In fact, 
all of the recipients of NZB marrow produced substantial amounts of antibody. DBA/2 and (NZB 
X  DBA/2)F1  recipients of DBA/2  marrow  were completely tolerant.  NZB  recipients of DBA/2 
marrow produced an intermediate amount of antibody following challenge that was significantly 
greater than that produced by DBA/2 recipients of DBA/2 marrow but significantly less than that 
produced by NZB recipients of NZB marrow. 1030  PRE-T CELL  DEFECT  IN NZB  MICE 
findings in that the defect in NZB marrow prethymocytes was manifested even  in a 
normal nonautoimmune  host. However, normal DBA/2 marrow in an NZB host did 
not fully correct the NZB tolerance defect. 
The Role of the Thymic Epithelium  in  Tolerance Induction to BGG in Recipients of NZB or 
DBA/2 Marrow.  To directly assess the effect of the source of the thymic epithelium 
upon tolerance induction, neonatally thymectomized female and castrated male (NZB 
X  DBA/2)F1 mice, at 2-3 wk of age, received a  thymic epithelial graft under the re- 
nal  capsule.  The  thymic epithelial donors  were  1-d-old DBA/2,  NZB,  or  (NZB  X 
DBA/2)F1 female mice. Before implantation, the grafts were irradiated. At  12-16 wk 
of age, the mice were  lethally irradiated and reconstituted with  107 T  cell-depleted 
NZB  or DBA/2  bone  marrow  cells. The  results of this  experiment  are depicted in 
Fig. 4. 
Tolerance was not observed in recipients of NZB marrow regardless of the donor 
strain of the thymic graft. Substantial and equal responses to challenge were made in 
recipients of DBA/2  thymic grafts as well as  (NZB  X  DBA/2)F1  and  NZB  thymic 
grafts, provided they had received NZB marrow stem cells. In contrast, recipients of 
DBA/2  marrow,  except  those  with  an  NZB  thymic  graft,  were  tolerant  to  BGG. 
Although recipients of an NZB thymic graft reconstituted with DBA/2 marrow made 
a  significantly  greater  response  to  challenge  than  did  the  other  DBA/2  marrow 
groups, the antibody response was significantly less than the nontolerant responses of 
recipients of NZB marrow. 
Discussion 
The NZB  mouse was  the first animal model of autoimmunity and is the classical 
animal  model of systemic lupus erythematosus  (1-4).  The multiple immune  abnor- 
malities that characterize NZB mice include B cell hyperactivity, T  cell abnormalities, 
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Flo. 4.  Neonatally thymectomized (NZB X DBA/2)F~ mice were grafted under the kidney capsule 
at 2 wk of age with a thymic epithelial graft from DBA/2, NZB, or (NZB X DBA/2)F1 mice. All 
mice were lethally  irradiated as adults and reconstituted  with  T  cell-depleted  DBA/2 or NZB 
marrow. Recipients of NZB marrow failed to become tolerant  no matter what  the source of the 
thymic epithelium. Recipients of DBA/2 marrow containing DBA/2 or (NZB x  DBA/2)F1 thymic 
epithelial  grafts were tolerant.  Those with  NZB  thymic  epithelial  grafts made an  intermediate 
amount  of antibody that was more than that produced by DBA/2 marrow plus a DBA/2 thymus 
but less than that produced by NZB marrow and any thymus. LASKIN ET AL.  1031 
and production of numerous autoantibodies (2-9). NZB mice share with other murine 
models of SLE (MRL-Mp/lpr/lpr,  BXSB,  (NZB ×  NZW)F1)  two important immune 
characteristics:  B  cell  hyperactivity  and  defects  in tolerance induction  (2-7,  20-29, 
33).  These  mice all  fail to become tolerant  to heterologous serum proteins, such as 
BGG and HGG. We and others (4, 23, 24) believe that the mechanisms that underlie 
defective tolerance induction to BGG and HGG are intimately related to the ultimate 
loss of self-tolerance associated with autoimmune disease.  As a  result, delineation of 
the cellular basis  for the BGG  tolerance defect  should help  to elucidate the cellular 
basis of the loss of self-tolerance. With this in mind, our laboratory has been actively 
investigating  the cellular mechanisms underlying  the tolerance defect  in  NZB  mice 
(23,  24,  28,  29).  Over  the past  few years, we have established  an  adoptive  transfer 
system  using  neonatally  thymectomized  (NZB  ×  DBA/2)FI  mice that  are  lethally 
irradiated  and  reconstituted  with cells  from one or both  parental  strains.  The  first 
series of experiments showed that the tolerance defect in NZB mice is associated with 
the NZB thymocyte (23). The expression of this defect in (NZB ×  DBA/2)Fx recipients 
reconstituted with  DBA/2  bone marrow and NZB  thymocytes  is suppressed  in the 
presence of androgens (24). 
The present studies are the logical extension of the earlier work. Using the adoptive 
transfer  system,  we  proceeded  to  determine  whether  the  abnormality  of the  NZB 
thymocyte originates  in  the  NZB  thymic epithelium  or in  a  prethymocyte  marrow 
stem cell. Our results indicate that a defective marrow stem cell is responsible. 
The  observed and  predicted  responses are summarized in Table  I.  The  data  are 
consistent  with  a  defect  in  the  NZB  marrow  pre-T  cell,  a  defect  that  requires  a 
thymus, any thymus, to allow the marrow pre-T cell to mature into a defective T  cell. 
An NZB  thymic epithelial  defect cannot, by itself,  account for the results obtained. 
TABLE  I 
Comparison of Observed and Predicted Tolerance Response to BGG 
Recipient 
Observed results  Expected results  for indicated abnormality 
NZB mar-  NZB mar- 
Neonatal  NZB mar-  NZB  row pre-T  row pre-T 
Thymic epithelial graft  or  Bone mar-  NZB-like  stem cell  stem cell 
thymec-  thymocyte donor  row donor  response  row pre-T  thymic  and NZB  and any 
tomy  stem cell  epithelium  thymic  thymic 
epithelium  epithelium 
DBA/2  No  --  DBA/2  No  No  No  No  No 
DBA/2  No  --  NZB  Yes  Yes  No*  No  Yes* 
NZB  No  --  DBA/2  No  No  Yes*  No  No* 
NZB  No  --  NZB  Yes  Yes  Yes  Yes  Yes 
(NZB ×  DBA/2)FI  No  --  DBA/2  No  No  No  No  No 
(NZB ×  DBA/2)FI  No  --  NZB  Yes  Yes  No*  No  Yes* 
(NZB ×  DBA/2)FI  Yes  DBA/2 graft  DBA/2  No  No  No  No  No 
(NZB ×  DBA/2)FI  Yes  DBA/2 graft  NZB  Yes  Yes  No*  No  Yes* 
(NZB x  DBA/2)Ft  Yes  (NZB ×  DBA/2)FI graft  DBA/2  No  No  No  No  No 
(NZB x  DBA/2)F1  Yes  (NZB ×  DBA/2)FI graft  NZB  Yes  Yes  No*  No  Yes* 
(NZB ×  DBA/2)F1  Yes  NZB graft  DBA/2  No  No  Yes*  No  No* 
(NZB ×  DBA/2)FI  Yes  NZB graft  NZB  Yes  Yes  Yes  Yes  Yes 
(NZB ×  DBA/2)FI  Yes  DBA/2 thymecytes  DBA/2  No  No  No  No  No 
(NZB ×  DBA/2)FI  Yes  NZB thymocytes  DBA/2  Yes  Yes:~  Yes  Yes  Yes 
(NZB ×  DBA/2)Fl  Yes  NZB thymocytes  NZB  Yes  Yes:[:  Yes  Yes  Yes 
(NZB ×  DBA/2)FI  Yes  DBA/2 thymocytes  NZB  No  Yes§  No  No  No§ 
* Distinguishes between the effects of an NZB and normal thymic epithelium. 
:~ The NZB thymocytes originated from NZB marrow pre-T stem cells and passed through NZB thymic epithelium. 
§ Distinguishes between the effects of an NZB marrow pre-T stem cell alone and an NZB marrow pre-T stem cell plus any thymic epithelium. 1032  PRE-T CELL DEFECT IN NZB MICE 
Although we have demonstrated that an NZB stem cell plus any thymic epithelium 
are necessary for an  NZB-like  tolerance  defect,  we have not  proven  that  the  NZB 
stem cell actually differentiates into an abnormal T  cell in the thymus. Nevertheless, 
we believe that  that  is  the  most  likely mechanism  to explain  the  requirements  for 
both the marrow stem cell and the thymic epithelium. 
Thus, the tolerance induction defect is determined by the mature NZB thymocyte. 
However, this cellular defect originates before the thymus in a prethymocyte marrow 
stem  cell.  That  this  manifestation  of NZB  autoimmune  disease  originates  in  the 
marrow is not without  precedent.  Numerous studies  (12-16)  have shown  that  NZB 
autoimmune disease is transferrable by administering NZB bone marrow to a normal 
irradiated  host.  Moreover,  a  general  stem  cell  abnormality has  been  suggested  by 
several workers (34,  35). However, those previous studies emphasized pre-B stem cell 
abnormalities.  The current  results  demonstrate  for the  first  time a  pre-T stem cell 
defect.  Moreover, this study helps to explain the findings of T  cell as well as B cell 
defects in NZB mice. 
The  results  reported  herein  relate  to  the  controversy  regarding  the  ability  or 
completeness of thymic epithelium  to "educate" marrow pre-T cells with  regard  to 
the function of the resulting peripheralized T  cells.  One school of thought holds that 
the thymus is capable of imparting functions to marrow pre-T cells that would not be 
attributable to the donor strain. This concept is supported by a number of experiments 
(36-39)  that demonstrate that in radiation chimeras, donor marrow leads to a T  cell 
function inapparent in the donor strain but characteristic of the recipient strain. The 
other  school  of thought  holds  that  marrow pre-T cells  can  express  their  potential 
despite  passage  through  a  "foreign"  thymus  (40-43).  It  is  possible  that  these  two 
possibilities are not mutually exclusive: marrow pre-T potential may be expressable 
and also the thymus may impart functions to marrow pre-T cells. 
The present experiments may be viewed in this context. Although we did not use 
H-2-incompatible recipients (the usual technique for studying radiation chimeras and 
possible thymic education),  we did  study mice with  different  T  cell  functions  with 
regard  to  tolerance.  We  found  that  the  NZB  marrow pre-T cell  could  express  its 
potential  to prevent  tolerance  induction  despite  passage through  a  thymus  from a 
strain that normally would express tolerance. We therefore suggest that  the marrow 
pre-T cell has all of the information necessary to become an abnormal T  cell  (with 
regard to tolerance) and that there is no education by the normal thymic epithelium 
to produce a "normal" tolerizable T  cell. 
However, subtle aspects of the study do suggest possible partial education  in  the 
opposite case. When normal marrow (marrow from a normal strain that is tolerizable) 
is passed through NZB thymic epithelium, the result, after tolerization and challenge, 
was  not  an  immune response  as  great  as  that  seen  in  the  fully  nontolerant  NZB. 
However, it was also not a fully tolerant response. This result suggests the possibility 
that the NZB thymic epithelium might impart some "education" to pre-T cells that 
normally would be rendered fully tolerant, thereby making the resulting T  cells less 
susceptible to tolerogenic signals. Further work on the detailed phenotypes of the T 
cells that result from these chimeras will be necessary to fully evaluate this possibility. 
In  conclusion,  the  present  studies  suggest  that  the  cellular  defect  in  NZB  mice 
responsible  for  abnormal  tolerance  induction  to  BGG  resides  in  a  prethymocyte 
marrow stem cell. This defect is necessary and sufficient for the prevention of normal LASKIN ET AL.  1033 
tolerance  induction,  provided  it  is  allowed  to  mature  in  the  presence  of thymic 
epithelium.  NZB thymic epithelium,  however, is not necessary for the expression of 
an NZB-like response to BGG. This study helps to resolve an area of uncertainty: the 
relative contribution of NZB marrow and thymic defects to the expression of immune 
abnormalities. It is clear that previous studies showing transfer or lack of transfer of 
abnormalities  from NZB  mice to  nonautoimmune  strains  might  have differed,  de- 
pending upon the presence or absence of a  thymus in the recipient and the maturity 
of the  NZB  donor cells.  In addition,  our results  demonstrate  that  a  marrow pre-T 
stem cell can express an abnormal phenotype despite attempts at  "education" by a 
normal thymic epithelium. Moreover, normal thymic epithelium that fails to properly 
educate the pre-T cell to a  normal phenotype is necessary for the maturation of the 
abnormal pre-T cell into an abnormal T  cell. In addition to elucidating an important 
aspect  of the  cellular  basis  of NZB  abnormalities,  this  observation  has  important 
implications for understanding the complexity of pre-T cell education by the thymus. 
Whether or not the NZB T  cell that interferes with tolerance does so by interfering 
with normal suppression mechanisms, as has recently been described in other systems 
(44,  45), requires further study. 
Summary 
NZB mice manifest a  defect in tolerance induction  by deaggregated heterologous 
gamma globulins.  We  have used  an  adoptive  transfer system  to  study  the  defect. 
Thymectomized, intact,  or thymectomized recipients given thymic epithelial  grafts 
were studied after lethal irradiation and reconstitution with NZB, DBA/2, or (NZB 
×  DBA)F1 marrow depleted of mature T  cells. NZB thymocytes were responsible for 
the tolerance defect of NZB mice. The information for the defect was present in the 
NZB  marrow prethymocyte.  That  defect  could  only be expressed when  there  was 
further maturation in association with a thymus. However, the normal DBA/2 thymic 
epithelium  served  as well  as  the  abnormal  NZB  thymic epithelium.  These studies 
resolve existing conflicts as to whether the NZB marrow or thymus is responsible for 
the loss of tolerance in association with autoimmunity. 
The authors wish to thank Ms. Elizabeth Novotny for her expert technical assistance,  and Ms. 
Martha McDonald for her preparation of the manuscript. 
Received  for publication 30 November 1981. 
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